This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US House staff say passage of Prevail Act, PERA patent legislation unlikely

By Nick Robertson ( March 3, 2025, 20:27 GMT | Insight) -- Despite bipartisan commitments to advance the Patent Eligibility Restoration Act and the Prevail Act in the Senate, a senior House Judiciary Committee staffer said the bills have no chance of passing in the House, painting a dim future for the efforts.Any hope to pass major Section 101 patent eligibility or Patent Trial and Appeal Board reform in the Senate may yet be dashed by the House, according to senior staffers who spoke at a conference today*....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections